Neuropsychiatric Aspects of HIV and AIDS

Embed Size (px)

Citation preview

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    1/27

    Case Summary

    42 years old Vietnamese man, who is a known case ofAIDS for 3 years, currently on HAART treatment,presented with a 2 months history of worsening memory,keep forgetting things associated with motor dysfunction(unable to carry out daily routine activities). Patient alsohas been feeling depressed for the past 2monthsassociated with lose of appetite and insomnia. He is

    unable to concentrate and becomes tired easily. Past medical history of Pneumocystic carinni infection

    and is a substance abuser.

    No other significant history

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    2/27

    Physical examination nothing significant

    MSE Appearance : dress appropriately, good eye contact, co-

    operative with some degree of psychomotor retardation

    Speech : rate was slow, normal quantity.

    Mood & Affect : Depressed, affect was restricted.

    Thought & Perception: No obsession or delusion. Feelingworthless/guilt. Suicidal ideation. No hallucination.

    Cognition: MMSE score 13 (unable to draw the clock, nogood concentration with impaired short and long termmemory)

    Judgement & Insight : Poor judgement and partial insight.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    3/27

    Investigation

    FBC

    U&E

    Urine FEME and Urine toxicology

    LFT

    LP CXR

    CT and MRI of brain

    Blood Culture

    Tests for herpes simplex, CMV, cryptococcal and VDRL

    HIV viral load and CD4 count

    Results : everything was normal, except very high viral load and CD4 was

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    4/27

    Diagnosis

    HIV associated Dementia / AIDS dementia complex

    Major Depressive Disorder?

    To rule out other general medical conditions due toAIDS.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    5/27

    NEUROPSYCHIATRICASPECTS OF HIV & AIDS

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    6/27

    Introduction

    HIV epidemic was identified in the 1980s, and

    neurologists described several HIV related CNS

    syndromes within the first several years of the

    epidemic.

    These include acquired immunodeficiency syndrome

    (AIDS) dementia, the associated AIDS mania,

    increased rates of depression, and psychiatricconsequences of CNS injuries

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    7/27

    HIV transmission

    HIV is a retrovirus. HIV-1 is the primary causative agent for most HIV

    related disorders

    HIV is present in blood, semen, cervical and vaginal

    secretions, and, to a lesser extent, saliva, tears, breastmilk, and the cerebrospinal fluid of those who areinfected.

    Modes of transmission include Heterosexual and homosexual intercourse

    Needles Blood products

    Vertical transmission

    The risk for transmission is higher with higher viral loadsand with the coexistence of sexually transmitteddiseases that compromise skin or mucosal integrity.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    8/27

    AIDS develops 8 11 years after infection

    The virus binds to the CD4 receptor on T4

    lymphocytes

    The virus injects ribonucleic acid (RNA) into the

    lymphocyte

    HIV pathophysiological mechanisms gradually

    disable all T4 lymphocytes and destroy cellmediated immunity, and opportunistic infections

    develop

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    9/27

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    10/27

    Epidemiology

    Estimated 33 million people have been infected withHIV worldwide

    More than 12 million deaths as result

    The chance of becoming infected after a singleexposure to an HIV infected person is relatively low:

    0.8 3.2% for unprotected receptive anal intercourse

    0.05 0.15% with unprotected vaginal sex

    0.32% after puncture with an HIV contaminated needle

    0.67% after using a contaminated needle to inject

    drugs

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    11/27

    Classification

    The Center of Disease Control (CDC) classifies AIDS

    based on CD4+ counts and the presence or

    absence of HIV associated clinical conditions

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    12/27

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    13/27

    Clinical manifestation About 30% of person infected with HIV experience a flulikesyndrome 3 6 weeks after becoming infected

    Most never notice any symptoms immediately or shortly aftertheir infection

    The flulike symdrome include Fever Myalgia

    Headaches

    Fatigue

    Gastrointestinal symptoms

    Rash Splenomegaly

    Lymphadenopathy

    The two most common coinfections in person infected with HIVwho have AIDS are Pneumocystis carinii pneumonia andKaposis sarcoma

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    14/27

    Investigations

    Serum testing

    Enzyme linked immunosorbent assay (ELISA)

    Western blot The ELISA is the initial screen. The western blot is more

    specific and is used to confirm positive ELISA results

    Seroconversion is the change after HIV infection

    from a negative HIV antibody test result to apositive HIV antibody test result

    Usually occurs 6 12 weeks after infection but maytake 6 12 months

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    15/27

    HIV In Psychiatric

    Primary HIV neurocognitive disorders: Asympomatic neurocognitive impairment

    HIV mild neurocognitive disorder

    HIV associated dementia

    Other primary HIV neurobiological complications: Meningitis

    Vacuolar myelopathy

    Neuropathies and myopathy

    Secondary neurobiological complications: Infections Neoplasia

    CVS

    Drugs/nutritional/metabolic

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    16/27

    HIV In Psychiatric

    Presentations:

    Delirium

    Dementia

    Minor cognitive motor disorder

    Major Depressive Disorder

    Anxiety Disorders

    Sleep Disorders

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    17/27

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    18/27

    HIV Associated Dementia / AIDS

    Dementia Complex

    The cumulative prevalence of HIV dementia in the

    lifetime of an infected adult has been reported to be

    near 15 percent, although the incidence has decreased

    by about 50 percent since the introduction of HAART. HIV-associated dementia is generally seen in late stages

    of HIV illness, usually in patients who have had a CD4+

    count under 200 cells per microliter.

    Furthermore, certain risk factors have been associated

    with eventual development of HIV dementia, namely,

    higher HIV RNA viral load, lower educational level,

    older age, anemia, illicit drug use, and female sex.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    19/27

    Clinically, the dementia presents with the typicaltriad of symptoms seen in other subcorticaldementias

    memory and psychomotor speed impairments,

    depressive symptoms,

    movement disorders.

    Initially, patients may notice slight problems withreading, comprehension, memory, and mathematicalskills, but since these symptoms are subtle, they maybe overlooked or discounted as fatigue and illness.

    Later, patients develop more global dementia, withmarked impairments in naming, language, andpraxis.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    20/27

    Motor symptoms are also often subtle in early

    stages, including

    occasional stumbling while walking or running slowing of fine repetitive movements

    slight tremor.

    In late stages, motor symptoms may be quite severe,

    with marked difficulty in smooth limb movements,

    especially in the lower extremities.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    21/27

    Apathy is a common early symptom of HIV-associated dementia

    A frank depressive syndrome also commonly

    develops, typically with irritable mood andanhedonia instead of sadness and crying spells

    Sleep disturbances are common, as is weight loss

    Psychosis develops in a significant number of

    patients, typically with paranoid ideas

    Overall, HIV-associated dementia is rapidly

    progressive, usually ending in death within two

    years.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    22/27

    Criteria (Grants & Atkinson)

    HIV-1 associated Dementia

    Marked acquired impairment in cognitive functioning,

    involving at least 2 ability domains (memory, attention).

    The impairment produces marked interference with dayto day functioning.

    Has been present for at least 1 month.

    Pattern of cognitive impairment does not meet criteria

    for delirium.

    There is no evidence of another cause that could

    explain the dementia.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    23/27

    HIV-1 associated Mild Neurocognitive Disorder (MND)

    acquired impairment in cognitive functioning, involving atleast 2 ability domains (memory, attention), at least 1.0standard deviation below the mean for age and educationappropriate norms using neuropsychological tests.

    The impairment produces at least mild interference in dailyfunctioning at least one of these: self report, observation byothers.

    Present for at least 1 month. Does not meet criteria for dementia or delirium

    No evidence of another preexisting cause.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    24/27

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    25/27

    Major depression is a risk factor for HIV infectionby virtue of its impact on behavior, intensification of

    substance abuse, exacerbation of self-destructivebehaviors, and promotion of poor partner choice inrelationships.

    Depression can be seen as a vector of HIV

    transmission. So, HIV is a causal factor in depression and that

    depression is a causal factor in HIV transmission andits morbidity.

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    26/27

    Conclusion

    Important role for mental

    health care in HIV treatmentand prevention

  • 8/6/2019 Neuropsychiatric Aspects of HIV and AIDS

    27/27